ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,248Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 2094

$785K Total Retail Price of All Prescriptions

Rank: 185 out of 2094

714 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 714 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 714 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 11,309 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 551 509 1 1
AMLODIPINE BESYLATE 524 488 2 2
LEVOTHYROXINE SODIUM 419 355 3 3
METFORMIN HCL 365 304 4 8
METOPROLOL TARTRATE 342 302 5 10
LISINOPRIL 337 312 6 7
FUROSEMIDE 322 260 7 6
ATORVASTATIN CALCIUM 317 295 8 5
METOPROLOL SUCCINATE 311 256 9 9
DIOVAN 274 268 10 13
WARFARIN SODIUM 219 184 11 11
HYDROCHLOROTHIAZIDE 200 163 12 12
JANUVIA 199 160 13 35
AMLODIPINE BESYLATE-BENAZEPRIL 174 150 14 58
DIOVAN HCT 168 159 15 28
ZOLPIDEM TARTRATE 161 129 16 14
BISOPROLOL-HYDROCHLOROTHIAZIDE 155 122 17 148
OMEPRAZOLE 143 136 18 4
AZITHROMYCIN 140 119 19 27
LOSARTAN POTASSIUM 140 105 19 17
ATENOLOL 134 130 21 21
POTASSIUM CHLORIDE 133 113 22 24
PLAVIX 126 123 23 38
CLOPIDOGREL 125 120 24 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 119 25 55
GLIPIZIDE ER 119 116 26 126
LIPITOR 114 113 27 39
CRESTOR 113 87 28 15
NEXIUM 110 103 29 16
ADVAIR DISKUS 109 57 30 36
CARVEDILOL 108 106 31 19
ALLOPURINOL 108 72 31 50
TRAMADOL HCL 107 81 33 33
ATENOLOL-CHLORTHALIDONE 107 95 33 220
LOSARTAN-HYDROCHLOROTHIAZIDE 104 89 35 52
NAPROXEN 104 82 35 84
TAMSULOSIN HCL 104 91 35 29
SYNTHROID 99 80 38 44
PAROXETINE HCL 94 94 39 77
PANTOPRAZOLE SODIUM 93 86 40 37
CIPROFLOXACIN HCL 92 82 41 81
GLIPIZIDE 90 72 42 82
PRAVASTATIN SODIUM 87 87 43 18
LANTUS SOLOSTAR 83 55 44 76
FLUTICASONE PROPIONATE 81 58 45 41
CLONIDINE HCL 80 73 46 62
MELOXICAM 79 59 47 49
PROAIR HFA 78 49 48 45
GLYBURIDE-METFORMIN HCL 78 68 R 48 94
SPIRIVA 76 60 50 60
MECLIZINE HCL 74 68 51 103
VERAPAMIL ER 73 55 52 161
CELEBREX 72 72 53 74
CLOTRIMAZOLE-BETAMETHASONE 72 69 53 91
RAMIPRIL 72 61 53 48
ENALAPRIL MALEATE 68 61 56 25
TRAMADOL HCL-ACETAMINOPHEN 67 62 57 100
GABAPENTIN 65 50 58 23
ENALAPRIL-HYDROCHLOROTHIAZIDE 64 55 59 213
GLYBURIDE 61 40 R 60 95
TRIAMTERENE-HCTZ 60 58 61 87
TORSEMIDE 59 59 62 118
PROCRIT 58 54 63 271
SPIRONOLACTONE 57 57 64 93
TRICOR 56 47 65 99
ALENDRONATE SODIUM 54 37 66 30
GLIPIZIDE XL 54 42 66 122
DONEPEZIL HCL 53 53 68 20
LANTUS 52 39 69 66
DIGOXIN 51 47 70 51
AMOX TR-POTASSIUM CLAVULANATE 51 44 70 107
BENAZEPRIL HCL 50 42 72 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.